Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults

American Journal of Medical Genetics, Part A

Volumn 161, Issue 6, 2013, Pages 1319-1322

  Leschziner, Guy D ^a,b   Golding, John F ^c,d   Ferner, Rosalie E ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cognition; Neurofibromatosis; Sleep

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONFUSION; DISEASE ASSOCIATION; EMPLOYMENT STATUS; EPWORTH SLEEPINESS SCALE; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 1; PERIODIC LIMB MOVEMENT DISORDER; PHENOTYPE; PITSSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SOMNOLENCE; UNEMPLOYMENT; COHORT ANALYSIS; COMPLICATION; GENETICS; MIDDLE AGED; NEUROFIBROMATOSIS 1; OUTPATIENT; PATHOPHYSIOLOGY; PREVALENCE; QUESTIONNAIRE; SLEEP; SLEEP WAKE DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; OUTPATIENTS; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; SLEEP; SLEEP WAKE DISORDERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84878252230     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35915     Document Type: Article

References (23)

1. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. 1989. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res 28:193-213.
2. Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N. 1992. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron 8:415-428.
3. Ferner RE. 2007. Neurofibromatosis 1 and neurofibromatosis 2: A twenty first century perspective. Lancet Neurol 6:340-351.
4. Ferner RE, Jackson MJ. 2011. Neurofibromatoses. In: Shorvon SD, Andermann F, Guerrini R, editors. Causes of Epilepsy. Cambridge University Press: Cambridge, UK.
5. Ferner RE, Hughes RAC, Weinman J. 1996. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138:125-133.
6. Ferner RE, Hughes RAC, Hall SM, Upadhyaya M, Johnson MR. 2004. Neurofibromatous neuropathy in neurofibromatosis 1. J Med Genet 41:837-841.
7. Hyman SL, Shores A, North KL. 2005. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 11:1037-1044.
8. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991. 14:540-545.
9. Johnson H, Wiggs L, Stores G, Huson SM. 2005. Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Dev Med Child Neurol 47:237-242.
10. Korf BR, Carrazana E, Holmes GL. 1993. Patterns of seizures in association with neurofibromatosis 1. Epilepsia 34:616-620.
11. Leger D, Morin CM, Uchiyama M, Hakimi Z, Cure S, Walsh JK. 2012. Chronic insomnia, quality of life and utility scores: Comparison with good sleepers in a cross-sectional international survey. Sleep Med 13:43-51.
12. Maquet P. 2011. Memory consolidation in insomnia patients: First steps towards understanding a complex issue. J Sleep Res 20:127-128.
13. Mouridsen SE, Sorensen SA. 1995. Psychological aspects of von Recklinghausen neurofibromatosis (NF1). J Med Genet 32:921-924.
14. National Institutes of Health Consensus Development Conference. 1988. Neurofibromatosis. Conference Statement. Arch Neurol 45:575-578.
15. North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB. 1997. Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 cognitive disorders task force. Neurology 48:1121-1127.
16. Okifuji A, Hare BD. 2011. Do sleep disorders contribute to pain sensitivity? Curr Rheumatol Rep 13:528-534.
17. Rotenberg VS. 2011. Sleep and psychiatric diseases. Handb Clin Neurol 98:557-576.
18. Samuelsson B, Riccardi V. 1989. Neurofibromatosis in Gothenberg, Sweden. III. Psychiatric and social aspects. Neurofibromatosis 2:84-106.
19. Siegel JM. 2009. The neurobiology of sleep. Semin Neurol 29:277-296.
20. Stradling JR, Huddart S, Arnold AG. 1981. Sleep apnoea syndrome caused by neurofibromatosis and superior vena cava obstruction. Thorax 36:634-635.
21. Williams JA, Su HS, Bernards A, Field J, Seghal A. 2001. A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science 293:2251-2256.
22. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608.
23. Zoller ME, Rembeck B. 1999. A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1. J Psychiatr Res 33:63-68.